U S Stem Cell Inc (USRM) Gross Profit Margin starting from the fourth quarter 2022 to fourth quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
U s Stem Cell Inc   (NONE: USRM)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


U S Stem Cell Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

USRM Gross Profit Margin (Dec 31 2022)
Q4 		(Sep 30 2022)
Q3 		(Jun 30 2022)
Q2 		(Mar 31 2022)
Q1 		(Dec 31 2021)
Q4
Y / Y Revenue Change -15.34 %
Seq. Revenue Change 40.2 %
Revenue In Millions $0.02
Gross Profit Margin 75.36 %
Gross Profit Margin Total Ranking # 805
Gross Profit In Millions $0.02
Y / Y Gross Profit Change 0.61 %
Seq. Gross Profit Change 67.57 %


Commenting fourth quarter 2022 Gross Profit Margin
U s Stem Cell Inc Gross Profit grew by 67.57 % in Q4 sequentially to 0 millions, while Revenue increased by 40.2 %, this led to improvement in the company's Gross Profit Margin to 75.36 %, above the U s Stem Cell Inc average Gross Profit Margin.


Observing fourth quarter 2022 results within Medical Laboratories industry 6 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 805, from total ranking in the previous quarter at 1383.
Learn about Gross Margin
USRM's Gross Profit Margin fourth quarter 2022 Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 149
Overall # 788

Gross Profit Margin Statistics
High Average Low
98.97 % 66.23 % 9.72 %
(Mar 31 2012)   (Sep 30 2014)


USRM Gross Income Trends • More of USRM's Profitabilty Ratios • USRM Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
USRM's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
USRM's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for USRM's Competitors
Gross Profit Margin Profit Margin for U S Stem Cell Inc 's Suppliers
Gross Profit Margin Profit Margin for USRM's Customers

You may also want to know
USRM's Annual Growth Rates USRM's Profitability Ratios USRM's Asset Turnover Ratio USRM's Dividend Growth
USRM's Roe USRM's Valuation Ratios USRM's Financial Strength Ratios USRM's Gross Profit Growth
USRM's Roa USRM's Inventory Turnover Ratio USRM's Growth Rates USRM's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2022, within Medical Laboratories Industry Gross Profit MarginDec 31 2022 MRQ Gross ProfitDec 31 2022 MRQ Revenue
Incyte Corporation  93.62 %$ 867.537  Millions$ 926.700  Millions
Bioaffinity Technologies Inc   91.21 %$ 0.003  Millions$ 0.004  Millions
Maxcyte inc   87.55 %$ 10.877  Millions$ 12.424  Millions
Vyant Bio Inc   86.96 %$ 0.040  Millions$ 0.046  Millions
Caredx Inc   77.35 %$ 63.727  Millions$ 82.384  Millions
Veracyte Inc   75.85 %$ 60.903  Millions$ 80.297  Millions
U s Stem Cell Inc   75.36 %$ 0.015  Millions$ 0.020  Millions
Castle Biosciences Inc   75.17 %$ 28.818  Millions$ 38.338  Millions
Exact Sciences Corporation  72.37 %$ 400.208  Millions$ 552.995  Millions
Inotiv Inc   71.14 %$ 87.324  Millions$ 122.754  Millions
Fresh2 Group Ltd  69.19 %$ 1.208  Millions$ 1.746  Millions
Burning Rock Biotech Limited  67.47 %$ 55.101  Millions$ 81.662  Millions
Nrc Health  63.33 %$ 24.156  Millions$ 38.144  Millions
Luna Innovations Inc  60.99 %$ 19.335  Millions$ 31.701  Millions
Hologic Inc  57.52 %$ 617.900  Millions$ 1,074.200  Millions
Ispecimen inc   52.40 %$ 1.552  Millions$ 2.962  Millions
Mdxhealth Sa  51.87 %$ 19.219  Millions$ 37.054  Millions
Exagen Inc   50.85 %$ 6.528  Millions$ 12.837  Millions
Butterfly Network Inc   47.93 %$ 9.556  Millions$ 19.936  Millions
Charles River Laboratories International inc   45.16 %$ 496.718  Millions$ 1,099.843  Millions
American Shared Hospital Services  45.07 %$ 2.270  Millions$ 5.037  Millions
Genetron Holdings Ltd  43.25 %$ 40.804  Millions$ 94.344  Millions
Natera Inc   41.65 %$ 90.482  Millions$ 217.252  Millions
Centogene N v   41.63 %$ 22.132  Millions$ 53.170  Millions
Koninklijke Philips Nv  40.35 %$ 8,057.280  Millions$ 19,966.240  Millions
Psychemedics Corporation  39.37 %$ 2.245  Millions$ 5.703  Millions
Iqvia Holdings Inc   35.62 %$ 1,332.000  Millions$ 3,739.000  Millions
Somalogic Inc   35.19 %$ 6.625  Millions$ 18.829  Millions
Quest Diagnostics Inc  32.49 %$ 758.000  Millions$ 2,333.000  Millions
Capforce Inc   31.40 %$ 0.227  Millions$ 0.722  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.